East African Community2023-07-172023-07-172018-04East African Community. (2018). Controlling the burden of liver disease through integrating hepatitis A and B vaccination into the national immunization programs of the EAC partner states. Policy Brief No. 4, 2018. East African Communityhttps://doi.org/10.60682/vsr0-3x52EAC Policy Brief on Aflatoxin Prevention and ControlLiver cancer is a leading cause of deaths in the world. Chronic hepatitis B infection causes 80 percent of liver cancer cases in the EAC region. The combination of aflatoxin exposure with hepatitis infection especially among people, who are malnourished or living with HIV results in a double-disease burden that increases disease severity, reduces survivability and heightens liver cancer prevalence. The economic losses to residents of all EAC partner states associated with morbidity and mortality from aflatoxin-attributable liver cancer is of a high magnitude. There is an urgent need to prioritize the prevention of Hepatitis A and B infections by administration of immunizations for all age group in the EAC Partner States.enControlling the burden of liver disease through integrating hepatitis A and B vaccination into the national immunization programs of the EAC partner statesOther